The FORCE Blog
Our blog features information and personal perspectives on topics of interest to the hereditary cancer community.

Stay up to date on research and information

Sign Up for FORCE Newsletters
Education > Our Blog > National Hereditary Cancer Week 2023  

Your information is used for the sole purpose of sending information about hereditary cancer and updates on FORCE programs and campaigns. To stop receiving these updates, click unsubscribe at the bottom of any email. If you need additional support, or have any questions, please contact [email protected].

National Hereditary Cancer Week 2023  

August 31, 2023

National Hereditary Cancer Week 2023  

National Hereditary Cancer Week (NHCW) and National Previvor Day serve as important reminders of the impact that hereditary cancer has on families. This time of year is an opportunity to spotlight hereditary cancer, impart knowledge and save lives. We hope you’ll add your voice to our #1FORCECommunity, so we can make a difference together!  

“NHCW is a chance to educate and spread awareness about hereditary cancer. As many as 90% of the millions of people who have a genetic mutation that causes or predisposes them to cancer are unaware of their risk. Let’s use this week to reach as many of these individuals as we can.” – Dr. Sue Friedman, FORCE Founder and Executive Director 

This year, National Hereditary Cancer Week is September 24 – September 30, and National Previvor Day is September 27. It has been 13 years since Congress unanimously passed a resolution (H. Res. 1522) establishing the first-ever National Hereditary Breast and Ovarian Cancer Week and National Previvor Day. Four years ago, FORCE renamed the week to ensure that all people affected by hereditary cancer are recognized and supported.  

National Hereditary Cancer Week is a time to acknowledge and honor everyone with a genetic mutation that increases their cancer risk, as well as the families and caregivers that support them. This includes people with Lynch syndrome or an inherited mutation in BRCA1/2, ATM, BRIP1, CHEK2, PALB2, PTEN, RAD51C/D or other gene associated with hereditary cancer. If you are a hereditary cancer survivor, previvor, caregiver or family member, this week is about honoring you and sharing information to help others who may be at an increased risk.   

Spreading awareness will save lives 

National Hereditary Cancer Week is an opportunity for healthcare providers, advocacy organizations and others affected to come together and raise awareness. We hope you will join in efforts to inform others about hereditary cancer risk so they can educate themselves and make informed medical decisions to protect their health. 

Help us spread the word 

Join us and show your support by: 

  • Following FORCE on Facebook, Instagram, YouTube and LinkedIn.  
  • Telling your friends about National Hereditary Cancer Week and National Previvor Day, both in person and on social media. 

  • Tagging your social media posts with #HereditaryCancerWeek, #PrevivorDay and #1FORCECommunity.  
  • Bringing FORCE brochures to your healthcare providers (you can order them for free online).  

Collectively, we can honor and remember all who have been impacted by hereditary cancer and, most importantly, spread the word so that others can learn as well. Knowledge is power!  

Posted in: FORCE And FORCE Impact , Hereditary Cancer - General
Tags: Previvor , National Hereditary Cancer Week


September 6, 2023

Francis vierra says:
I am currently in breast cancer treatment and am first TO KNOW that I have BRCA2 gene now my four sons are undergoing tests my oldest is positive


September 6, 2023

Tony Clark says:
My wife is a breast cancer survivor who fortunately does not have a BRCA mutation. I however am BRCA2 positive which led our two adult daughters to seek genetic counseling. Unfortunately they are both BRCA2 positive as well. After considerable research and professional counseling, my oldest daughter (32) decided to have a double mastectomy. The procedure went well and although her recovery has just begun she is empowered by her decision to take control of her health. Our youngest daughter (24) understands that her path does not have to be the same as her sister's. Also empowered, she looks forward to best controlling her health with appropriate exams and screening. When the time comes we trust her decision will be equally thoughtful and pray successful.


September 16, 2023

Catherne Tata says:
At age 65 I am the first in my family who is diagnosed with ATM as a carrier. I have had 4 different cancers. I have lost 10 immediate family members (siblings, father, niece and aunt and uncle) to cancer at young ages. I also have primary immune deficincy due to ATM. Kowledge is power. Knowing this allows for high risk preventative screening with early diagnosis and treatment. It saved my life and would save the lives of so many.


September 21, 2023

Virginia Joines says:
Our family has a BRCA2 mutation. Three of us have had breast cancer. My first breast cancer was 30 years ago. 15 years ago I learned I had the mutation and after speaking with our geneticist and my oncologist, decided to have prophylactic bilateral mastectomies in 2008. I am now being treated for breast cancer again. This time on the contralateral side. Fortunately, I have access to excellent care and I expect to beat it again.


Leave a Reply